Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia and Thyringia, Germany

Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia and Thyringia, Germany - SCENARIO-T

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022088

Enrollment

2650

Registered

2020-06-03

Start date

2020-06-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: 2400 pregnant women and 150 members of the hospital care team in the department of obstetrics. The observation period is three months. Group 2: 100 SARS-CoV-2 positive pregnant women

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age >= 18 yrs; Written informed consent; Pregnant women or members of the hospital care team in the department of obstetrics

Exclusion criteria

Exclusion criteria: lack of ability to provide written informed consent

Design outcomes

Primary

Measure	Time frame
Rate of seropositive pregnant women in pregnancy in three cohorts (1st month, 2nd month, 3rd month)	—

Secondary

Measure	Time frame
Time of SARS-CoV-2-Infection of mother and fetus/newborn Complications in pregnancy Mode and complications of delivery Neonatal complications Rate of seropositive members of the hospital care team in the department of obstetrics	—

Countries

Germany

Contacts

Public ContactAlexander Hein

Frauenklinik, Universitätsklinikum Erlangen

alexander.hein@uk-erlangen.de09131-85-44982

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026